NEW YORK Havas' Euro RSCG said it has launched a healthcare practice called Euro RSCG Tonic.
The unit has several major clients, including Amgen, GlaxoSmithKline, Novartis, Sanofi-Aventis, Schering-Plough and Stryker.
"Healthcare revenue within Euro RSCG New York has more than doubled over the past two years," said David Jones, CEO of Euro RSCG in New York, in a statement. "Our healthcare team has attracted some of the best talent in the business and is working with some of the best-known brands in healthcare. We saw this as a great opportunity to consolidate this talent and expertise into one important unit."
Tonic's management team consists of Phil Silvestri and Rich Roth, managing directors and co-executive creative directors, and managing directors Paul Klein (for direct-to-consumer products) and Marty Susz (over-the-counter). The team reports to Jones.
"There is great satisfaction in getting work that really communicates, motivates and moves people through all the hurdles of research and regulation. No one's pitching softballs in this league" said Roth.
Euro RSCG Tonic launches amid continued debate over DTC drug advertising. Today, Bristol-Myers Squibb (which is not on the shop's roster) said it would no longer advertise drugs directly to consumers in their first year on the market [Adweek Online, June 15].
—Adweek staff report